13.60
Carlsmed Inc (CARL) 最新ニュース
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News
Carlsmed's Aprevo Implants Receive CMS NTAP Approval For Cervical Fusion Procedures Under FY2026 IPPS Final Rule - 富途牛牛
Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks
AI medtech firm Carlsmed prices $100.5M IPO - MSN
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg.com
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery - MarketScreener
Carlsmed announces completion of first aprevo cervical procedure - TipRanks
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Ortho Spine News
Carlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal
Carlsmed Launches $100.5 Million Initial Public Offering - Global Legal Chronicle
Carlsbad-based medical technology company begins trading on Nasdaq - MSN
Latham & Watkins Advises on Carlsmed, Inc.’s US$100.5 Million Initial Public Offering - Latham & Watkins LLP
Carlsmed Insider Bought Shares Worth $899,985, According to a Recent SEC Filing - MarketScreener
Carlsmed director Philip Young buys $900k in shares By Investing.com - Investing.com Canada
Carlsmed (CARL) director Sidow buys $199,995 in shares - Investing.com Australia
Carlsmed (CARL) director Sidow buys $199,995 in shares By Investing.com - Investing.com Canada
Carlsmed director Philip Young buys $900k in shares - Investing.com
Carlsmed director Mittendorff buys $20 million in shares By Investing.com - Investing.com India
Carlsmed director Mittendorff buys $20 million in shares - Investing.com
Carlsmed, Inc. Completes Initial Public Offering - TipRanks
Carlsmed 6.7M share IPO priced at $15 per share - MSN
Carlsmed: Redefining Precision And Personalization In Spine Surgery With AI-Powered Aprevo - RTTNews
Carlsmed, Inc.(NasdaqGS: CARL) added to NASDAQ Composite Index - MarketScreener
Carlsmed: Spine Play Does Not Have My Backing Yet (NASDAQ:CARL) - Seeking Alpha
Carlsmed times IPO with reimbursement boon - Axios
Carlsmed Inc. (CARL): MedTech Makes Uninspiring Debut, Opens Flat and Trades Below Issue - Smartkarma
AI Spine Surgery Firm Carlsmed Shares Fall 3.3% After IPO - Bloomberg
Carlsmed begins trading on Nasdaq at $15 per share - Investing.com
Carlsmed (CARL): Assessing the Post-IPO Dip in a High-Growth MedTech Disruptor - AInvest
Carlsmed begins trading on Nasdaq at $15 per share By Investing.com - Investing.com Canada
Carlsmed, Inc Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Carlsmed, Inc Rings the Opening Bell - Nasdaq
Carlsmed Prices $100.5 Million IPO - MarketScreener
Carlsmed's $100.5M IPO: A Strategic Play in AI-Driven Personalized Spine Surgery - AInvest
Carlsmed Sets IPO Price at $15 per Share to Raise $100.5M - AInvest
Carlsmed raises USD 100.5M through IPO - Medical Buyer
Carlsmed launches IPO of 6.7 million shares priced $14-16 each - Investing.com Australia
Carlsmed prices IPO at $15 per share, to begin trading today - Investing.com Australia
Carlsmed's AI-Driven Spine Surgery Innovation and IPO Valuation: A Strategic Buy Opportunity for Long-Term Growth - AInvest
Carlsmed prices IPO at $15 per share, raising $100.5 million - Investing.com Australia
Carlsmed's AI-Driven Spine Surgery Platform and Its IPO Implications - AInvest
Carlsmed prices IPO at $15 per share, raising $100.5 million By Investing.com - Investing.com Canada
大文字化:
|
ボリューム (24 時間):